Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by INVOS Cerebral Oximeter Users

John Hsu, MD, Director of Anesthesiology
Presbyterian Intercommunity Hospital Inc
Analysis of: Survey: Hospital EHR Adoption Rate is Below 12% (www.govhealthit.com)
The lack of a comprehensive EHR implementation suggests that we are failing at our goal of improving the healthcare system.  While the article highlights many problems, very few solutions are offered to remedy this part of our healthcare crises. The key implications are: 1....
Analysis of: Higher Risk of Death and Stroke in Patients Given Beta Blockers After Non-Cardiac Surgery (POISE Trial) (pharmalive.com)
To most in anesthesia, a "good anesthetic" is when the patient is delivered to the post anesthesia care unit in a stable fashion.  However, it may be more complicated and success is determined by 30-180 day markers of myocardial or CNS morbidity.  Unfortunately, this type of followup is not...
Analysis of: Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults (www.bio-medicine.org)
Prompt and effective pain control to decrease procedural pain is a significant benefit in the ER, ICU and OR department       
Analysis of: FDA Issues Warning About Botox Deaths (www.pharmalot.com)
1) Dissemination of information on Botox related complications is important.  2) Lay press coverage of Botox related complications will likely transiently reduce Botox utilization. 3) A "black box" warning from the FDA will serve no useful purpose. 
John Hsu, MD, Director of Anesthesiology
Presbyterian Intercommunity Hospital Inc
November 16, 2007
Theword of mouth
Analysis of: Cigna reaches deal on doctors' rankings (news.yahoo.com)
Missing in the article is the fact patients will still go to the physicians that they like regardless of the rating system.  This rating system of doctors is really economic credentialling.  Insurance companies will lower reimbursement unit values of physicians that are not rated...
John Hsu, MD, Director of Anesthesiology
Presbyterian Intercommunity Hospital Inc
Analysis of: FDA Warns About Misuse Of Fentora Cancer Pain Drug (www.medicalnewstoday.com)
Because the FDA warns about the misuse Of Fentora as a Cancer Pain Drug,  I hope that physicians will be very carefull about prescribing this very potent opiate medication.  Fortunately, the company Cephalon is correcting the problem without taking away the important role of this drug...
John Hsu, MD, Director of Anesthesiology
Presbyterian Intercommunity Hospital Inc
Analysis of: New Medicare Regulations Adopted To Reduce Certain Hospital Infections And Medical Errors (www.medicalnewstoday.com)
Under new Medicare regulations, hospitals will no longer receive higher payments for the additional costs associated with treating patients for certain hospital- acquired infections and medical errors. The new rules will give hospitals a powerful new incentive to improve patient care, according to Consumers...
Luc Jasmin, MD, PhD, Attending Neurosurgeon and a Research Scientist
Cedars-Sinai Medical Center
Analysis of: Medtronic Buys Kyphon For $3.9 Billion (www.forbes.com)
Will the recent purchase of Kyphon by Medtronic signals the end of kyphoplasty? No because arcuoplasty does not restore vertebral height. Vertebroplasty, kyphoplasty and arcuoplasty essentially achieve the same goals, which brings up the question, do we need all three techniques? Arcuoplasty is the...
John Hsu, MD, Director of Anesthesiology
Presbyterian Intercommunity Hospital Inc
Analysis of: MDs offer new services, for $3,600 yearly fee (www.boston.com)
Is access to healthcare equal for everyone or only for the wealthy.
Analysis of: CeNeS Licenses New Intravenous Anaesthetic to Ono in Japan (www.pipelinereview.com)
This intravenously administered seditive agent has a huge potential market.  The company, which is based out of Cambridge, England (and NOT in the USA) has a strong scientific advisory board.  Dr. Peter Sebel from New York is a well know premier scientific researcher in the field of intravenous...

Page : 1 2 Next1 to 10 of 18

Analytics


Generated at 2009-01-08T13:34:52.320